MPWR vs REGN · P/E 112, rev $2.21B vs P/E 14, rev $14.34B
Monolithic Power Systems Inc (MPWR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Monolithic Power Systems Inc (MPWR) is a semiconductors company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MPWR revenue for 2024-12-31 was $2.21B. Net income was $1.79B. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. MPWR currently screens at market cap $77.49B and trailing P/E 112.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MPWR currently screens at market cap $77.49B and trailing P/E 112.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MPWR and REGN stock pages for the full models.
Not investment advice.